MRC1 and cancer: The percentage of patients with PGVs in MMR genes within this unselected glioblastoma cohort were compared to the percentage of patients with PGVs in MMR genes within other unselected cancer cohorts20,36–38 and the gnomAD v2.11 (non-cancer) cohort39.